Form 4 for PTGX Protagonist Therapeutics, Inc
Accepted 2024-01-11 00:00:00 ET · period of report 2024-01-09 · accession 0001104659-24-003435 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-11 | 2024-01-09 | PTGX | Gupta Suneel | Chief Development Off | M - OptEx | $7.38 | +5,000 | 192.6K | +3% | +$36.9K |
| D | 2024-01-11 | 2024-01-09 | PTGX | Gupta Suneel | Chief Development Off | S - Sale+OE | $25.00 | -5,000 | 187.6K | -3% | -$125.0K |
| D | 2024-01-11 | 2024-01-09 | PTGX | Gupta Suneel | Chief Development Off | M - OptEx | $0.00 | -5,000 | 45.0K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-09 | M | A | 5,000 | $7.38 | 192,567 | D | — | — | |
| 2 | Common | Common Stock | 2024-01-09 | S | D | 5,000 | $25.00 | 187,567 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2024-01-09 | M | D | 5,000 | $0.00 | 45,000 | D | $7.38 · — to 2029-01-14 | 5,000 Common Stock | (F2) These stock options are fully vested. |